Cibc World Markets Corp Biomarin Pharmaceutical Inc Transaction History

Cibc World Markets Corp

$14.8 Billion
Q2 2025

A detailed history of Cibc World Markets Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 7,985 shares of BMRN stock, worth $419,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,985

Previous 8,672 7.92%

Holding current value

$419,372

Previous $613,000 28.55%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$54.08 - $68.32 $37,152 - $46,935	-687 Reduced 7.92%	7,985 $438,000
Q1 2025 May 13, 2025	BUY	$61.25 - $72.83 $3,491 - $4,151	57 Added 0.66%	8,672 $613,000
Q4 2024 Feb 10, 2025	SELL	$61.93 - $70.49 $151,728 - $172,700	-2,450 Reduced 22.14%	8,615 $566,000
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $57,424 - $78,074	832 Added 8.13%	11,065 $777,000
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $889,587 - $1.1 Million	-11,952 Reduced 53.87%	10,233 $842,000
Q1 2024 May 13, 2024	SELL	$83.81 - $99.0 $20.8 Million - $24.6 Million	-248,057 Reduced 91.79%	22,185 $1.94 Million
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $20.6 Million - $26.6 Million	270,242 New	270,242 $26.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $2.79 Million - $3.3 Million	34,000 New	34,000 $2.88 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $2.23 Million - $2.78 Million	-30,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $2.15 Million - $2.74 Million	30,000 New	30,000 $2.65 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $732,707 - $910,208	-10,091 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $115,854 - $211,220	-1,612 Reduced 13.77%	10,091 $768,000
Q2 2020 Aug 12, 2020	SELL	$79.55 - $124.22 $250,105 - $390,547	-3,144 Reduced 21.18%	11,703 $1.44 Million
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $13,631 - $18,498	191 Added 1.3%	14,847 $1.26 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $531,063 - $713,675	8,263 Added 129.25%	14,656 $1.24 Million
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $141,877 - $179,156	2,105 Added 49.09%	6,393 $431,000
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $402,728 - $453,327	4,288 New	4,288 $416,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $1.01 Million - $1.21 Million	-13,034 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$80.76 - $95.13 $1,615 - $1,902	-20 Reduced 0.15%	13,034 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.05 Million - $1.24 Million	13,054	13,054 $1.22 Million

Others Institutions Holding BMRN

# of Institutions

692

Shares Held

187M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $9.76B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Biomarin Pharmaceutical Inc Transaction History